HEK-Dual™ mTLR7

Murine TLR7 (NF-κB-SEAP / KI-[IL-8]Lucia) dual-reporter HEK293 cells

HEK-Dual™ mTLR7 (NF/IL8) cells were generated from HEK-Dual™ Null cells by stable transfection of the mouse TLR7 (mTLR7) gene.

Due to the knockout of TLR3 and TLR5, these cells enable the study of mTLR7 signaling without interference from other TLRs.

They respond to low concentrations of TLR7 agonists such as R848, an imidazoquinoline compound. They do not respond to other TLR agonists or to the cytokine TNF-α (see validation sheet).

HEK-Dual™ mTLR7 (NF/IL8) cells are resistant to hygromycin B, Zeocin® and blasticidin. They should be maintained in growth medium supplemented with hygromycin B and Zeocin®.

References:

1. Ohta K. et al., 2014. TLR-mediated interleukin-8 production by human submandibular gland epithelial cells. Mol Med Rep. 10(5):2377-82.
2. Roebuck KA. et al., 1999. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res. 19(5):429-38. 

Figures

Detection of the NF-κB response using QUANTI-Blue™. HEK-Dual™ mTLR7 (NF/IL8) and HEK-Blue™ mTLR7 cells were stimulated with various TLR agonists: R848 (TLR7/8 agonist; 300 ng/ml), CL264 (TLR7 agonist; 300 ng/ml), Gardiquimod™ (TLR7 agonist; 300 ng/ml), Poly(I:C) (TLR3 agonist; 3 µg/ml), FLA-ST (flagellin from S. typhimurium, TLR5 agonist; 100 ng/ml), and TNF-α (10 ng/ml). The TLR3, TLR5 and TNFR activities due to the endogenous expression of these receptors in HEK-Blue™ mTLR7 cells are shown in gray. After 24 hour incubation, NF‑κB‑induced SEAP activity was assessed using QUANTI‑Blue™ and reading the optical density (OD) at 655 nm.

Detection of the IL-8 response using QUANTI-Luc™. HEK-Dual™ mTLR7 (NF/IL8) cells were stimulated with TLR7 agonists: R848 (TLR7/8 agonist; 300 ng/ml), CL264 (TLR7 agonist; 300 ng/ml) and Gardiquimod™ (TLR7 agonist; 300 ng/ml). After 24 hour incubation, activation of the IL-8 promoter was determined by measuring the relative light units (RLUs) in a luminometer using QUANTI‑Luc™, a Lucia luciferase detection reagent. The activation of the IL-8 promoter is expressed as fold increase relative to untreated cells which was calculated by dividing the RLUs for the treated cells by the RLUs for the untreated cells.

Specifications

Antibiotic resistance: blasticidin, hygromycin, Zeocin®

Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™

Guaranteed mycoplasma-free

These cells are covered by a Limited Use License (See Terms and Conditions).

Contents

• 1 vial containing 3-7 x 10⁶ cells
• 1 ml of Hygromycin B Gold (100 mg/ml)
• 1 ml of Zeocin® (100mg/ml)
• 1 ml of Normocin™ (50 mg/ml)
• 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
• 1 tube of QUANTI-Luc™ 4 Reagent, a Lucia luciferase detection reagent (sufficient to prepare 25 ml)

Shipped on dry ice (Europe, USA, Canada, and some areas in Asia)

Details

EC50 values calculated for the NF-kB response using QUANTI-Blue™. HEK-Dual™ mTLR7 (NF/IL8) and HEK-Blue™ mTLR7 cells were stimulated for 24 hours with various TLR7 agonists: R848, CL264 and Gardiquimod™.

FAQ Cell Lines

Any questions about our cell lines ? Visit our frequently asked questions page